Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07815210 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase I Trial of HHK101 in Patients With Schizophrenia

Name: Phase I Trial of HHK101 in Patients With Schizophrenia — clinical trial record (NCT07815210)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorZhuhai Huahaikang Pharmaceutical Technology Co., Ltd.

Started2026-09-30

View on ClinicalTrials.gov ↗

This study aims to learn how the study drug is absorbed by the body, check for possible side effects, and see if the drug may help improve symptoms in patients with schizophrenia.

Trial Details

NCT Number	NCT07815210
Lead Sponsor	Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
Conditions	Schizophrenia
Enrollment	125 participants
Start Date	2026-09-30
Primary Completion	2028-10-31 (estimated)
Study Completion	2028-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-11